Onconova Therapeutics to Participate in Ladenburg Thalmann Virtual R&D Showcase on Narazaciclib in Endometrial Cancer May 12, 2023 08:00AM
Onconova Therapeutics to Participate in Ladenburg Thalmann Virtual R&D Showcase on Narazaciclib in Endometrial Cancer May 12, 2023 08:00AM
Onconova Therapeutics to Present at the Ladenburg Thalmann 2022 Healthcare Conference Sep 22, 2022 08:00AM
Onconova Therapeutics to Present at the Ladenburg Thalmann 2022 Healthcare Conference Sep 22, 2022 08:00AM
UPDATE: Ladenburg Thalmann Starts Onconova Therapeutics (ONTX) at Buy Mar 1, 2022 06:44AM


Sep 28, 2021 04:05PM Onconova Therapeutics, Inc. Announces Closing of $21 Million Public Offering of Common Stock
Sep 28, 2021 04:05PM Onconova Therapeutics, Inc. Announces Closing of $21 Million Public Offering of Common Stock
Sep 24, 2021 08:00AM Onconova Therapeutics (ONTX) Prices 5M Share Offering at $4.20/sh
Sep 24, 2021 08:00AM Onconova Therapeutics, Inc. Announces Pricing of $21 Million Public Offering of Common Stock
Sep 24, 2021 08:00AM Onconova Therapeutics, Inc. Announces Pricing of $21 Million Public Offering of Common Stock